Evidence map›Paper›PMID 32856604›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Racial Differences in

Matthew G Varga, Julia Butt, William J Blot, Loïc Le Marchand, Christopher A Haiman, Yu Chen, Sylvia Wassertheil-Smoller, Lesley F Tinker, Richard M Peek, John D Potter and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Prevalence ofFrontiers in oncology · 2022
    Pooled it
  3. Potential pathogenesis ofFuture science OA · 2026
    Article
  4. Microbiology and molecular biology reviews : MMBR · 2026
    Review
  5. Seroprevalence of Helicobacter pylori Infection Among Asymptomatic Patients Served by a Safety-Net Healthcare System.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026
    Article
  6. Article
  7. Southern medical journal · 2026
    Article
  8. Review
  9. International journal of molecular sciences · 2025
    Review
  10. Article
  11. Prevalence of Helicobacter pylori cagA virulence factor and validation of serological tests in a population from Northeastern Brazil.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  12. Lancet regional health. Americas · 2025
    Review
  13. Assessment ofHeliyon · 2024
    Article
  14. Article
  15. Racial disparities of gastric cancer in the USA: an overview of epidemiology, global screening guidelines, and targeted screening in a heterogeneous population.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Review
  16. The prevalence and risk factors ofMicrobiota in health and disease · 2024
    Article
  17. Helicobacter pylori Burden in the United States According to Individual Demographics and Geography: A Nationwide Analysis of the Veterans Healthcare System.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Article
  18. Cancer Progress and Priorities: Gastric Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  19. Observational
  20. Frontiers in microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 2 countries.

Matthew G Varga *Department of Epidemiology, University of North Carolina Gillings School for Global Public Health and the Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.ORCID 0000-0002-2075-3224
Julia Butt *Cancer Control and Population Health Sciences Program, Duke Cancer Institute, Durham, North Carolina.ORCID 0000-0001-7738-8611
William J BlotDivision of Epidemiology, Vanderbilt University Medical Center, Nashville, Tennessee.
Loïc Le MarchandEpidemiology Program, University of Hawai'i Cancer Center, Honolulu, Hawaii.
Christopher A HaimanUniversity of Southern California and USC Norris Comprehensive Cancer Center, Los Angeles, California.
Yu ChenDepartment of Population Health, New York University School of Medicine, New York, New York.
Sylvia Wassertheil-SmollerDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-5447-4653
Lesley F TinkerDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Richard M PeekDivision of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
John D PotterDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.ORCID 0000-0001-5439-1500
Timothy L CoverDepartment of Medicine and Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center; Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee.ORCID 0000-0001-8503-002X
Terry HyslopCancer Control and Population Health Sciences Program, Duke Cancer Institute, Durham, North Carolina.
Anne Zeleniuch-JacquotteDepartment of Population Health, New York University School of Medicine, New York, New York.
Sonja I BerndtInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, Maryland.
Allan HildesheimInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, Maryland.ORCID 0000-0003-0257-2363
Tim WaterboerInfections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Michael PawlitaInfections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-4720-8306
Meira EppleinCancer Control and Population Health Sciences Program, Duke Cancer Institute, Durham, North Carolina. meira.epplein@duke.edu.ORCID 0000-0001-5646-6430
German Cancer Research Center · DEDuke University · USFred Hutch Cancer Center · USNational Cancer Institute · USNew York University · USVA Tennessee Valley Healthcare System · USAlbert Einstein College of Medicine · USCancer Center of Hawaii · USUniversity of North Carolina at Chapel Hill · USUSC Norris Comprehensive Cancer Center · USVanderbilt University Medical Center · US

Funding

Understanding Population Differences in Cancer: The MEC StudyU01CA164973 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI HAIMAN, CHRISTOPHER ALAN, LE MARCHAND, LOIC · 2015 to 2025
$37.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Role of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TIMOTHY L COVER · 2009 to 2026
$27.5M
Southern Community Cohort StudyU01CA202979 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLOT, WILLIAM J., SHRUBSOLE, MARTHA J. · 2016 to 2025
$22.0M
H.Pylori Relationship to Digestive Diseases and CancerR01CA077955 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2003 to 2026
$9.7M
Structure-function analysis of H. pylori VacAR01AI039657 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TIMOTHY L COVER · 1996 to 2026
$8.3M
Helicobacter Pylori and Gastrointestinal BiologyR01DK058587 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PEEK, RICHARD M. · 2001 to 2024
$7.8M
Type IV Protein Secretion in Helicobacter pyloriR01AI118932 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COVER, TIMOTHY L, OHI, MELANIE DIANE · 2016 to 2025
$6.7M
The NYU Women's Health StudyUM1CA182934 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZELENIUCH-JAQUOTTE, ANNE · 2015 to 2019
$3.7M
Cancer Control Education ProgramT32CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa B Gilkey, Melissa A. Troester · 2017 to 2026
$3.7M
The NYU Women's Health StudyU01CA182934 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHEN, YU · 2020 to 2023
$2.7M
Helicobacter pylori protein-specific antibodies and colorectal cancer riskR01CA190428 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI EPPLEIN, MEIRA · 2015 to 2018
$2.3M
BLRD VA I01 BX004447NCI NIH HHS P01 CA116087NCI NIH HHS R01 CA077955NCI NIH HHS R01 CA190428NCI NIH HHS T32 CA057726NCI NIH HHS U01 CA164973NCI NIH HHS U01 CA182934NCI NIH HHS U01 CA202979NCI NIH HHS UM1 CA182934NHLBI NIH HHS HHSN268201600001CNHLBI NIH HHS HHSN268201600002CNHLBI NIH HHS HHSN268201600003CNHLBI NIH HHS HHSN268201600004CNHLBI NIH HHS HHSN268201600018CNIAID NIH HHS R01 AI039657NIAID NIH HHS R01 AI118932NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK058587
6 · The paper itself

Abstract

backgroundPrevalence of POPULATION: We sought to assess prevalence of CagA-positive

methodsWe utilized multiplex serology to quantify antibody responses to

resultsAfrican Americans were three times more likely to be

conclusionsAmong individuals in the United States born from the 1920s to 1960s, IMPACT: Our findings suggest a widening racial disparity in the prevalence of the most virulent form of

Indexed as

AgedFemaleHelicobacter pyloriHumansMaleMiddle AgedPrevalenceRace FactorsRisk FactorsUnited States

Identifiers

PMID32856604
PMCPMC7584346
OpenAlexW3077381575

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.